BSECompany UpdateFundraise5d ago
Krishna Institute of Medical Sciences Ltd
QIP - Monitoring Agency Report
Krishna Institute of Medical Sciences Ltd has submitted a Monitoring Agency Report for the quarter ended September 30, 2026, as required by SEBI regulations, following the QIP issue of ₹1,500 crores. The report, issued by CARE Ratings Limited, confirms that there were no deviations from the objects of the issue.
NSEMonitoring Agency ReportFundraise5d ago
Krishna Institute of Medical Sciences Limited
Monitoring Agency Report
Krishna Institute of Medical Sciences Limited has raised Rs. 600 crores through a preferential issue of warrants, with the monitoring agency report for the quarter ended September 30, 2026, indicating no deviation from the objects of the issue.
BSECompany UpdateFundraise5d ago
Shukra Pharmaceuticals Ltd
Reg 32
Shukra Pharmaceuticals Ltd has filed a disclosure under Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, stating that there is no deviation or variation in the utilization of proceeds from the preferential issue of convertible warrants.
NSEMonitoring Agency ReportFundraise5d ago
Krishna Institute of Medical Sciences Limited
Monitoring Agency Report
Krishna Institute of Medical Sciences Limited has submitted a Monitoring Agency Report for the quarter ended September 30, 2026, related to the Qualified Institutional Placement (QIP) issue of ₹1,500 crores. The report, issued by CARE Ratings Limited, confirms that there were no deviations from the objects of the issue.
NSEGeneral UpdatesFundraise5d ago
Raymond Realty Limited
General Updates
Raymond Realty Limited has informed the Exchange regarding allotment of 66,57,373 securities pursuant to Preferential Issue vide circular resolution passed on November 04, 2026.
NSEStatement of deviation(s) or variation(s) under Reg. 32Fundraise5d ago
Vintage Coffee And Beverages Limited
Statement of deviation(s) or variation(s) under Reg. 32
Vintage Coffee And Beverages Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32, stating that there is no deviation or variation in use of proceeds raised through Preferential Issue for the Quarter ended 30th September, 2026.
BSECompany UpdateFundraise5d ago
Vintage Coffee And Beverages Ltd
Statement of deviation/utilisation for the quarter ended 30.09.2026
Vintage Coffee And Beverages Ltd has submitted a statement of deviation/utilisation for the quarter ended 30.09.2026, stating no deviation or variation in the use of proceeds raised through preferential issue.
BSECompany UpdateFundraise5d ago
Capfin India Ltd
As per the attached.
Capfin India Ltd has filed a statement confirming no deviation or variation in the utilization of proceeds raised through a preferential issue of equity shares for the quarter ended September 30, 2026.
BSECompany UpdateFundraise5d ago
Raymond Realty Ltd
Please find enclosed herewith the intimation under Regulation 30 of SEBI Listing Regulations for Allotment.
Raymond Realty Ltd has announced the allotment of 66,57,373 convertible warrants to J K Investors (Bombay) Limited on a private placement basis. The warrants are convertible into 1 fully paid-up equity share of the company at a price of ₹614/- each. The allotment has been made upon receipt of the upfront subscription amount of ₹153.50/- per Warrant, equivalent to 25% of the total issue price.
BSECompany UpdateFundraise5d ago
Stellant Securities (India) Ltd
ALLOTMENT OF SECURITIES
Stellant Securities (India) Ltd has announced the allotment of equity shares and warrants to non-promoters and promoters, respectively, as approved by its board of directors. The company has received 25% of the total consideration for the warrants.
BSECompany UpdateFundraise5d ago
Oval Projects Engineering Ltd
AS INCLOSED
Oval Projects Engineering Ltd has announced the outcome of its Board Meeting, where it considered and approved several items, including unaudited financial results for the half year ended September 30, 2026, and a proposal to raise funds through the issuance of warrants convertible into equity shares. The company is evaluating a comprehensive capital infusion plan that will include participation from both promoter and non-promoter investor categories.
BSEGeneralFundraise5d ago
Stellant Securities (India) Ltd
ALLOTMENT OF SECURITIES
Stellant Securities (India) Ltd has announced the allotment of equity shares and warrants to non-promoters and promoters, respectively, as approved by the Board of Directors. The allotment is based on the consideration for cash to the allottees, and the company has received 25% of the total consideration.
BSECompany UpdateFundraise5d ago
Cubex Tubings Ltd
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding the proposed preferential issue of convertible warrants at the Extraordinary General Meeting scheduled for 6 November 2026
Cubex Tubings Ltd has announced a proposed preferential issue of up to 50,00,000 convertible warrants at ₹150 per warrant, aggregating to up to ₹75 crore, to fund land and civil works, and a vacuum induction melting furnace. The company confirms that the issue does not trigger an open offer requirement.
NSEGeneral UpdatesFundraise5d ago
Cubex Tubings Limited
General Updates
Cubex Tubings Limited has proposed a preferential issue of up to 50,00,000 convertible warrants at ₹150 per warrant, aggregating to up to ₹75 crore, to fund land and civil works, and a vacuum induction melting furnace. The company claims that the acquisition will not trigger an open offer under the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
BSECompany UpdateFundraise5d ago
Amines & Plasticizers Ltd
Please find enclosed herewith a Circular inviting Unsecured Deposit in Form DPT-1, along with the Statutory Auditors Certificate, Deposit Scheme and Application Form, dispatched to the Members of the Company.
Amines & Plasticizers Ltd has submitted a circular inviting unsecured deposits from members, as per the Companies Act, 2013 and rules made thereunder. The circular is available on the company's website and can be downloaded from the link provided.
NSEGeneral UpdatesFundraise5d ago
Amines & Plasticizers Limited
General Updates
Amines & Plasticizers Limited has informed the Exchange about dispatch of Circular to the Members of the Company inviting Unsecured Deposits in Form DPT-1, along with the Statutory Auditors Certificate, Deposit Scheme and Application Form.
BSECorp. ActionFundraise5d ago
Evonile Pharma Ltd
Intimation is hereby given that the record date for determining the rights entitlement for the Rights Issue of partly paid-up shares of the Company shall be Wednesday, November 11, 2026.
Evonile Pharma Ltd has announced the record date for its rights issue of partly paid-up shares, set at Wednesday, November 11, 2026. The rights issue aims to raise ₹9,000.00 million and will offer 1,02,87,832 partly paid-up equity shares at an issue price of ₹860 per share.
NSEMonitoring Agency ReportFundraise5d ago
EFC (I) Limited
Monitoring Agency Report
EFC (I) Limited has submitted a Monitoring Agency Report for the quarter ended September 30, 2026, regarding the utilization of proceeds raised through Rights Issue dated May 25, 2026. The report, issued by CARE Ratings Limited, states that the utilization of gross proceeds is in line with the objects of the issue.
BSECompany UpdateFundraise5d ago
EFC (I) Ltd
Monitoring Agency Report for utilization of funds for the quarter ended September 30, 2026.
EFC (I) Ltd has submitted a Monitoring Agency Report for the quarter ended September 30, 2026, on the utilization of proceeds raised through Rights Issue dated May 25, 2026, as per SEBI Regulations and Monitoring Agency Agreement.
BSECompany UpdateFundraise5d ago
Cosmic CRF Ltd
Pursuant to Regulation 32 of the SEBI (LODR) Regulations, 2015, we are enclosing herewith Statement of no deviation or variation in the utilization of proceeds of Preferential Issue of Equity Shares and Convertible Share Warrants of the Company.
Cosmic CRF Ltd has submitted a statement to BSE confirming no deviation or variation in the utilization of proceeds from its Preferential Issue of Equity Shares and Convertible Share Warrants for the half year ended September 30, 2026.